Each ingredient is chosen for its ability to support metabolic balance, digestive health, and cardiovascular wellness
The medications work as a GIP and GLP-1 receptor agonists, activating the hormone receptors and working to slow digestion and, in turn, increase satiety and reduce food cravings
Among firms offering health benefits, 40% of small firms and 69% of large firms offer programs to help workers stop smoking or using tobacco, 34% of small firms and 62% of large firms offer programs to help workers lose weight, and 33% of small firms and 70% of large firms offer some other lifestyle or behavioral coaching program
GLP-1-based medicines such as semaglutide and tirzepatide are licensed in the UK for specific uses
The real question is causality vs shared susceptibility
MHRA-authorised alternatives for weight management include semaglutide (Wegovy), liraglutide (Saxenda), and tirzepatide (Zepbound)